Drug intelligence / Profile preview

Noxa peptide

Development stage
Preclinical
Lead developer
University of California, San Francisco
Modality
Peptides
Administration
Intravenous
01

Overview

Noxa peptide is a cell-permeable peptide derived from the BH3 domain of the pro-apoptotic protein Noxa (PMAIP1). It functions as a BH3 mimetic that selectively binds to and inhibits the anti-apoptotic protein Mcl-1. By sequestering Mcl-1, the peptide releases pro-apoptotic proteins such as Bim, which then initiate the mitochondrial pathway of apoptosis. Research indicates that Noxa peptide can overcome multicellular resistance in 3D tumor spheroids of lung cancer and mesothelioma, particularly when used to sensitize cells to other chemotherapeutic agents or BH3 mimetics like ABT-737. It is primarily used as a research tool to study apoptotic priming and the Bcl-2 family repertoire in various cancer models.

Other names
Noxa BH3 peptidecell-permeable Noxa peptide
02

Targets

BCL2A1 (B-cell lymphoma 2-related protein A1)MCL1 (Myeloid cell leukemia sequence 1)

Beyond the preview

Go deeper on Noxa peptide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Noxa peptide.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call